Free Trial

Chorus (OTCMKTS:CHRYY) Stock Price Down 6.7% - Should You Sell?

Chorus logo with Computer and Technology background

Chorus Ltd. (OTCMKTS:CHRYY - Get Free Report) fell 6.7% on Monday . The company traded as low as $24.13 and last traded at $24.13. 200 shares were traded during trading, a decline of 68% from the average session volume of 627 shares. The stock had previously closed at $25.85.

Chorus Price Performance

The stock has a 50 day simple moving average of $24.66 and a 200 day simple moving average of $23.70.

Chorus Company Profile

(Get Free Report)

Chorus Limited, together with its subsidiaries, engages in the provision of fixed line communications infrastructure services in New Zealand. It offers phone and broadband services for residential and business customers; data and voice services; and solutions for transport and infrastructure. The company also builds and maintains a network of fibre and copper cables, local telephone exchanges, and cabinets.

See Also

Should You Invest $1,000 in Chorus Right Now?

Before you consider Chorus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chorus wasn't on the list.

While Chorus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines